{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:51:57Z","timestamp":1776880317304,"version":"3.51.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1998,12,1]],"date-time":"1998-12-01T00:00:00Z","timestamp":912470400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1998,12]]},"DOI":"10.1007\/bf03348036","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T09:42:26Z","timestamp":1396604546000},"page":"725-731","source":"Crossref","is-referenced-by-count":14,"title":["Role of colestipol in the treatment of hyperthyroidism"],"prefix":"10.1007","volume":"21","author":[{"given":"Philippe","family":"Hagag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nissenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,29]]},"reference":[{"key":"BF03348036_CR1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.2.6088.688","volume":"2","author":"JS Staffurth","year":"1997","unstructured":"Staffurth J.S., Gibberd M.C., Fui S.T. Arterial embolism in thyrotoxicosis with atrial fibrillation. BMJ 2: 688, 1997.","journal-title":"BMJ"},{"key":"BF03348036_CR2","first-page":"1496","volume-title":"Principles and practice of endocrinology and metabolism","author":"EW Seely","year":"1990","unstructured":"Seely E.W., Williams G.H. The cardiovascular system and endocrine disease. In: Becker K.L. (Ed.), Principles and practice of endocrinology and metabolism. J.B. Lippincott, Philadelphia, 1990, p. 1496."},{"key":"BF03348036_CR3","first-page":"331","volume-title":"Principles and practice of endocrinology and metabolism","author":"KD Burman","year":"1990","unstructured":"Burman K.D. Hyperthyroidism. In: Becker K.L. (Ed.), Principles and practice of endocrinology and metabolism. J.B. Lippincott, Philadelphia, 1990, p. 331."},{"key":"BF03348036_CR4","first-page":"1516","volume":"76","author":"D Reinwein","year":"1993","unstructured":"Reinwein D., Benker G., Lazarus J.H., Alexander W.D. A prospective randomized trial of antithyroid drug dose in Graves\u2019 disease therapy. European Multicenter Study Group on Antithyroid Drug Treatment. J. Clin. Endocrinol. Metab. 76: 1516, 1993.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348036_CR5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1530\/acta.0.0530256","volume":"53","author":"F Bergman","year":"1966","unstructured":"Bergman F., Heedman P.A., Van der Linden W. Influence of cholestyramine on absorption and excretion of thyroxine in Syrian hamster. Acta Endocrinol. (Copenh.) 53: 256, 1966.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03348036_CR6","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1001\/jama.1969.03160100047012","volume":"208","author":"RC Northcutt","year":"1969","unstructured":"Northcutt R.C., Stiel J.N., Hollifield J.W., Stant E.G. Jr. The influence of cholestyramine on thyroxine absorption. JAMA. 208: 1857, 1969.","journal-title":"JAMA"},{"key":"BF03348036_CR7","first-page":"113","volume-title":"The Thyroid: a fundamental and clinical text","author":"JT Nicoloff","year":"1986","unstructured":"Nicoloff J.T. Physiologic and pathophysiologic implications of hormone binding. In: Ingbar S.H., Braverman L. (Eds.), The Thyroid: a fundamental and clinical text. J.B. Lippincott, New York, 1986, p. 113."},{"key":"BF03348036_CR8","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199512213332507","volume":"333","author":"MI Surks","year":"1995","unstructured":"Surks M.I., Stievert R. Drug therapy: drugs and thyroid function. N. Engl. J. Med. 333: 1688, 1995.","journal-title":"N. Engl. J. Med."},{"key":"BF03348036_CR9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/jps.2600630714","volume":"63","author":"WA Phillips","year":"1974","unstructured":"Phillips W.A., Schultz J.R., Stafford W.W. Effects of colestipol hydrochloride on drug absorption in rat: aspirin, L-thyroxine, phenobarbital, cortisone, and sulfa drugs. J. Pharm. Sci. 63: 1097, 1974.","journal-title":"J. Pharm. Sci."},{"key":"BF03348036_CR10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1210\/jcem-46-5-838","volume":"46","author":"JL Witztum","year":"1978","unstructured":"Witztum J.L., Jacobs L.S., Schonfeld G. Thyroid hormone and thyrotropin levels in patients placed on colestipol hydrochloride. J. Clin. Endocrinol. Metab. 46: 838, 1978.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348036_CR11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.7326\/0003-4819-115-8-658_2","volume":"115","author":"SM Harmon","year":"1991","unstructured":"Harmon S.M., Seifert C.F. Levothyroxine-cholestyramine interaction reempha-sized. Ann. Intern. Med. 115: 658, 1991.","journal-title":"Ann. Intern. Med."},{"key":"BF03348036_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-118-2-199301150-00006","volume":"118","author":"KMM Shakir","year":"1993","unstructured":"Shakir K.M.M., Michaels R.D., Hays J.H., Potter B.B. The use of bile acid sequestrants to lower serum thyroid hormones in iatrogenic hyperthyroidism. Ann. Intern. Med. 118: 112, 1993.","journal-title":"Ann. Intern. Med."},{"key":"BF03348036_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2265.1993.tb00970.x","volume":"38","author":"BL Solomon","year":"1993","unstructured":"Solomon B.L., Wartofsky L., Burman K.D. Adjunctive cholestyramine therapy for thyrotoxicosis. Clin. Endocrinol. (Oxf.) 38: 39, 1993.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348036_CR14","first-page":"3191","volume":"81","author":"M Mercado","year":"1996","unstructured":"Mercado M., Mendoza-Zubieta V., Bautista-Osorio R., Espinoza de los Monteros A.L. Treatment of hyperthyroidism with a combination of methimazole and cholestyramine. J. Clin. Endocrinol. Metab. 81: 3191, 1996.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348036_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2265.1995.tb02030.x","volume":"43","author":"G Benker","year":"1995","unstructured":"Benker G., Vitti P., Kahaly G., Raue F., Tegler L., Hirche H., Reinwein D., the European Multicenter Study Group. Response to methimazole in Graves\u2019 disease. Clin. Endocrinol. (Oxf.) 43: 257, 1995.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348036_CR16","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.1981.tb02965.x","volume":"14","author":"PA Dahlberg","year":"1981","unstructured":"Dahlberg P.A., Karlsson F.A., Lindstrom B., Wide L. Studies of thyroid hormone and methimazole levels in patients with Graves\u2019 disease on a standardized anti-thyroid drug regimen. Clin. Endocrinol. (Oxf.) 14: 555, 1981.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348036_CR17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2265.1988.tb01221.x","volume":"29","author":"AB Artzenius","year":"1988","unstructured":"Artzenius A.B., Elte J.W.F., Frolich M., Haak A. The significance of the initial FT4-index for the management of single daily dose methimazole treatment of hyperthyroidism. Clin. Endocrinol. (Oxf.) 29: 239, 1988.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03348036_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/eje.0.1340015","volume":"134","author":"B Nygaard","year":"1996","unstructured":"Nygaard B., Faber J., Heged\u00fcs L., Hansen J.M. 131I treatment of nodular non-toxic goitre. Eur. J. Endocrinol. 134: 15, 1996.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03348036_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jcem-63-1-125","volume":"63","author":"A Shiroozu","year":"1986","unstructured":"Shiroozu A., Okamura K., Ikenove H., Sato K., Nakashima T., Yoshinari M., Fujishima M., Yoshizumi T. Treatment of hyperthyroidism with a small single daily dose of methimazole. J. Clin. Endocrinol. Metab. 63: 125, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348036_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/jphysiol.1972.sp009762","volume":"221","author":"AP Hillier","year":"1972","unstructured":"Hillier A.P. Autoregulation of thyroxine secretion into bile. J. Physiol. 221: 471, 1972.","journal-title":"J. Physiol."},{"key":"BF03348036_CR21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1210\/jcem-35-2-250","volume":"35","author":"HV Barnes","year":"1972","unstructured":"Barnes H.V., Bledsoe T. A simple test for selecting the thionamide schedule in thyrotoxicosis. J. Clin. Endocrinol. Metab. 35: 250, 1972.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348036_CR22","first-page":"13","volume":"132","author":"DJ Bouma","year":"1980","unstructured":"Bouma D.J., Kammer H. A single daily dose methimazole treatment of hyperthyroidism. West. J. Med. 132: 13, 1980.","journal-title":"West. J. Med."},{"key":"BF03348036_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/acta.0.1100499","volume":"110","author":"DC McCruden","year":"1985","unstructured":"McCruden D.C., Hilditch T.E., Connel J.M.C., Alexander W.D. Kinetics of 123-iodine uptake and discharge by Perchlorate in studies of inhibition of iodide binding by antithyroid drugs. Acta Endocrinol (Copenh.) 110: 499, 1985.","journal-title":"Acta Endocrinol (Copenh.)"},{"key":"BF03348036_CR24","first-page":"9","volume":"185","author":"D Glinoer","year":"1987","unstructured":"Glinoer D., Hesch D., Lagasse R., Laurberg P. The management of hyperthyroidism due to Graves\u2019 disease in Europe in 1986. Results of an international survey. Acta Endocrinol. (Copenh.) 185 (Suppl.): 9, 1987.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03348036_CR25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03344959","volume":"17","author":"M Meyer-Gessner","year":"1994","unstructured":"Meyer-Gessner M., Benker G., Lederbogen S., Olbricht T.H., Reinwein D. Antithyroid drug-induced agranulocytosis: Clinical experience with ten patients treated at one institution and review of the literature. J. Endocrinol. Invest. 17: 29, 1994.","journal-title":"J. Endocrinol. Invest."},{"key":"BF03348036_CR26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/bdd.2510150604","volume":"15","author":"MA Al-Meshal","year":"1994","unstructured":"Al-Meshal M.A., El-Sayed Y.M., Al-Balla S.R., Gouda M.W. The effect of colestipol and cholestyramine on ibuprofen bioavailability in man. Biopharm. Drug Dispos. 15: 463, 1994.","journal-title":"Biopharm. Drug Dispos."},{"key":"BF03348036_CR27","first-page":"441","volume":"32","author":"SR Al-Balla","year":"1994","unstructured":"Al-Balla S.R., El-Sayed Y.M., Al-Meshal M.A., Gouda M.W. The effect of cholestyramine and colestipol on the absorption of diclofenac in man. Int. J. Clin. Pharmacol. Ther. 32: 441, 1994.","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"BF03348036_CR28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2125.1990.tb03843.x","volume":"30","author":"KT Kivisto","year":"1990","unstructured":"Kivisto K.T., Neuvonen P.J. The effect of cholestyramine and activated charcoal on glipizide absorption. Br. J. Clin. Pharmacol. 30: 733, 1990.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"BF03348036_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/j.1552-4604.1990.tb03434.x","volume":"30","author":"SC Forland","year":"1990","unstructured":"Forland S.C., Feng Y., Cutler R.E. Apparent reduced absorption of gemfibrozil when given with colestipol. J. Clin. Pharmacol. 30: 29, 1990.","journal-title":"J. Clin. Pharmacol."},{"key":"BF03348036_CR30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0002-9149(92)91264-5","volume":"70","author":"HR Superko","year":"1992","unstructured":"Superko H.R., Greenland P., Manchester R.A., Andreadis N.A., Schectman G., Hendriksen West N., Hunninghake D., Haskell W.L., Probstfield J.L. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia. Am. J. Cardiol. 70: 135, 1992.","journal-title":"Am. J. Cardiol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348036\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T02:44:08Z","timestamp":1565318648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,12]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1998,12]]}},"alternative-id":["BF03348036"],"URL":"https:\/\/doi.org\/10.1007\/bf03348036","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,12]]}}}